泛华控股集团 FANH 深 沪
等待开盘 02-17 09:30:00 美东时间
1.53
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 1.53
- 总市值 8.22万
- 52周最高 7.48
- 市盈率 静 2.11
- 换手率 0.00%
- 52周最低 1.06
- 委 比 0.00%
- 总股本 5.37万
- 历史最高 34.1459
- 量 比 0
- 振 幅 0.00%
- 历史最低 1.06
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多9月出险房企境外债务安排一览
久期财经讯，9月30日，“十四五”期间，为化解房地产风险，在金融支持房地产风险化解方面，政策端出台优化调整首付比、房贷利率等多项政策，并降低存量房贷利率，每年可...
2025-09-30 19:37
FangDD Announces Share Consolidation
FangDD Network Group Ltd. announced its share consolidation, merging every 16 ordinary shares into 1, effective June 9, 2025. Shareholders' ownership remains unchanged, with the consolidation aimed at meeting Nasdaq's minimum bid price requirement. The company had 62,472,674 shares before consolidation, reduced to 3,904,565 shares afterward.
2025-06-04 12:00
天睿祥盘中异动 快速拉升6.34%报2.18美元
北京时间2024年10月01日01时43分，天睿祥（TIRX.us）股票出现异动，股价大幅拉升6.34%。截至发稿，该股报2.18美元/股，成交量5.2979万股，换手率2.22%，振幅6.34%。 最近的财报数据显示，该股实现营业收入178345.00美元，净利润-2.61百万美元，每股收益-2.68美元，毛利数据暂无，市盈率-0.45倍。 机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。 天睿祥股票所在的保险行业中，整体跌幅为0.02%。其相关个股中，Selectquote, Inc.、泛华控股集团、Reliance Global Group, Inc.涨幅较大，Relian...
2024-10-01 01:43
Yuanbao Drives Business With Technology-Driven Insurance Services In Tough Market
Key Takeaways: Yuanbao has filed for an IPO in New York, reportedly seeking to raise a relatively modest $50 million in a deal that could value it at more than $400 million Despite a difficult Chinese insurance market, the company’s platform that uses big data to match potential buyers with the most suitable products is booming
2024-09-26 01:57
Waterdrop Stalls In Second Quarter, But Reaffirms Annual Growth Forecast
Key Takeaways: Waterdrop’s revenue fell 0.4% in the second quarter, but its profit rose fourfold as it controlled costs in what it described as a market filled with “challenges”
2024-09-09 21:25
Fanhua Subsidiary Signs Strategic Cooperation Agreement With Shanghai Biotecan Pharmaceuticals
Fanhua BluePlus and Biotecan will leverage their respective resources and service strengths to collaborate on cutting-edge medical testing, health management, cell therapy, and other modern high-end medical and health
2024-09-06 18:32
